Je was op zoek naar: ςυοκρασύχαπ (Grieks - Engels)

ιακ ατιαίδ ηνε όλλαβιπε η νατό ςυοκρασύχαπ εσ ςωίρυκ ακιλήνε υοτ υοπύτ ςητήβαιδ ςηδώραχκαΣ
however, taking into account some current practice and some data on sparing of insulin when associated to metformin, it should be mentioned in section 5.1 of the spc that the combination has been used in selected cases of patients.

νώκολπιπε νώκιτηβαιδ νωτ ησωίε ίετσαισυοραπ ιεχέ ςατιαίδ αίχυτοπα όπα αρετσύ αίεπαρεθ αιρύκ, ςω ηνί ροφτε ε ςαίεπαρεθ ιεχύτ νυοχέ ιοίοπο ιο υοπύτ ητήβαιδ ε ςίενεθσα ςυοκρασύχαπ εΣ 2 ηνίλυοσνι ε ή ςετνογάραπ ςύοκιτηβαιδιτνα ςυονε όναβ αλ
analysis of the results for overweight patients treated with metformin after failure of diet alone showed: • a significant reduction of the absolute risk of any diabetes-related complications in the metformin group (29.8 events/ 1000 patient-years) versus diet alone (43.3 events/ 1000 patients-years), p=0.0023, and versus the combined sulfonylurea and insulin monotherapy groups (40.1 events/ 1000 patients-years), p=0.0034; • a significant reduction of the absolute risk of diabetes-related mortality: metformin 7.5 events/ 1000 patient-years, diet alone 12.7 events/ 1000 patient-years, p=0.017; • a significant reduction of the absolute risk of overall mortality: metformin 13.5 events/ 1000 patient-years versus diet alone 20.6 events/ 1000 patients-years (p=0.011), and versus the combined sulfonylurea and insulin monotherapy groups 18.9 events/ 1000 patient-years, (p=0.021); • a significant reduction of the absolute risk of myocardial infarction: metformin 11 events/ 1000 patient-years, diet alone 18 events/ 1000 patient-years (p=0.01).

οτ ε ησέχσ ιεχέ υοπ ςήκολπιπε ετοπήδσαιο υονύδνικ υοτυλόπα υοτ ησωίε ήκιτνα ησ ιεξίεδ νυοχέ ονό ατιαίδ ε αίχυτοπα όπα ηνί ροφτε ε νακηθύεπαρεθ υοπ ςίενεθσα ςυοκρασύχαπ εσ νωτά σελετοπα νωτ ησυλάνα Η υοπύτ ητήβαιδ οτσ ςοτα ία υοτ ςηζόκυλγ ςητ υοχγέλε ύοκιτατνε 2.
cpmp/4082/00